论文部分内容阅读
Cancer chemotherapy patients often suffer from severe side effects caused by anti-cancer drugs.A promising way for overcoming this drawback is the use of an ultrasonic-triggered drug release system [1].Currently,we have developed a novel adriamycin ultrasonic triggered drug release and tracked drug delivery system (ADM-UTrS) on the basis of our previous adriamycin-modified gelatin nanogel with fluoride anion (ADM-GNMF) system [2].